Kidney Transplant Rejection Market to Witness Growth During the Study Period (2019-32),| Key Companies – AstraZeneca, Novartis, Takeda

Las Vegas, Nevada, United States DelveInsight’s “Kidney Transplant Rejection Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Kidney Transplant Rejection, historical and forecasted epidemiology as well as the Kidney Transplant Rejection market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Kidney Transplant Rejection Overview

Kidney Transplant Rejection is an immunological response that leads to inflammation with specific pathological changes in the allograft when the recipient’s immune system recognizes the nonself (foreign) antigen in the allograft, with or without dysfunction of the allograft.
Although both innate and adaptive immune systems play a significant role in rejection, the T lymphocytes are the principal cells that recognize the allograft. Some other costimulatory molecules and cytokines also have a role in this reaction. Depending on the histopathology and immunological characteristics, renal transplant rejections can be classified broadly as hyperacute rejection, acute rejection (antibody-mediated rejection, acute T-cell mediated rejection), chronic rejection, and a mixture of acute rejection superimposed on chronic rejection.

Kidney Transplant Rejection Epidemiology Insights

●Acute rejection rates are high (from 33% to 69%) among renal re-transplant patients [31], and there are growing numbers of patients awaiting re-transplantation.
●The incidence rate was found to be 1.1%-21.5%; most studies reported 3%-12% incidence, usually within the first year post-transplant.

Leading Companies Working in the Kidney Transplant Rejection Market
●Novartis Pharmaceuticals
●Hansa Biopharmaceuticals
●GlaxoSmithKline
●Bristol Myers Squibb
●Pfizer
●Velloxsis Pharmaceuticals
●Astellas Pharmaceuticals
And many others

Promising Therapies in the Kidney Transplant Rejection Pipeline
●Imlifidase
●Tacrolimus
●Sonazoid
●NI-0401
●Belimumab
●Bortezomib
●Thymoglobulin
And many others

Learn more about the key companies and emerging therapies @ Kidney Transplant Rejection Therapeutics Market Analysis

Scope of the Kidney Transplant Rejection Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, Japan]
Key Kidney Transplant Rejection Companies: Novartis Pharmaceuticals, Hansa Biopharmaceuticals, GlaxoSmithKline, Bristol Myers Squibb, Pfizer, Velloxsis Pharmaceuticals Astellas Pharmaceuticals, and many others.
Key Kidney Transplant Rejection Pipeline Therapies: Imlifidase, Tacrolimus, Sonazoid, NI-0401, Belimumab, Bortezomib, Thymoglobulin, and many others.
Therapeutic Assessment: Kidney Transplant Rejection current marketed and emerging therapies
Kidney Transplant Rejection Market Dynamics: Kidney Transplant Rejection market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL’s views, Analyst’s views, Kidney Transplant Rejection Market Access and Reimbursement

Table of Contents
1. Kidney Transplant Rejection Market Key Insights
2. Kidney Transplant Rejection Market Report Introduction
3. Kidney Transplant Rejection Market Overview at a Glance
4. Kidney Transplant Rejection Market Executive Summary
5. Disease Background and Overview
6. Kidney Transplant Rejection Treatment and Management
7. Kidney Transplant Rejection Epidemiology and Patient Population
8. Patient Journey
9. Kidney Transplant Rejection Emerging Drugs
10.7MM Kidney Transplant Rejection Market Analysis
11. Kidney Transplant Rejection Market Outlook
12. Potential of Current and Emerging Therapies
13. KOL Views
14. Kidney Transplant Rejection Market Drivers
15. Kidney Transplant Rejection Market Barriers
16. Unmet Needs
17. SWOT Analysis
18. Appendix
19.DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Download the sample pages @ Kidney Transplant Rejection Market Outlook

Trending Reports
●Hand Eczema
●Hereditary Angioedema

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Contact Us
Adya Kaul
+1(919)321-6187
info@delveinsight.com
https://www.delveinsight.com